Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)

Objective: to estimate quality of life changes in patients with rheumatoid arthritis (RA) while adding tocilizumab (TCZ) to therapy with disease-modifying antirheumatic drugs (DMARDs) and to study the efficiency and safety of the therapy in RA patients with an inadequate response to previous DMARD t...

Full description

Saved in:
Bibliographic Details
Main Authors: E Yu Panasyuk, V N Amirdzhanova, Anastasia Sergeyevna Avdeyeva, E L Luchikhina, E N Aleksandrova, A A Novikov, E L Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2013-04-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/773
Tags: Add Tag
No Tags, Be the first to tag this record!